Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dharmishta Parmar

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Breast Cancer Research : BCR|May 18, 2013
Overdiagnosis in breast cancer screening: the importance of length of observation period and lead timeStephen W Duffy, Dharmishta Parmar
Journal of Medical Screening|September 17, 2019
Concurrent participation in screening for cervical, breast, and bowel cancer in EnglandMatejka Rebolj, Dharmishta Parmar, Roberta Maroni, et al.
BMC Cancer|December 17, 2013
An ongoing case-control study to evaluate the NHS breast screening programmeNathalie J Massat, Peter D Sasieni, Dharmishta Parmar, et al.
BMC Cancer|December 16, 2014
An ongoing case-control study to evaluate the NHS Bowel Cancer Screening ProgrammeNathalie J Massat, Peter D Sasieni, Dharmishta Parmar, et al.
British Journal of Cancer|May 9, 2018
Addition of ultrasound to mammography in the case of dense breast tissue: systematic review and meta-analysisMatejka Rebolj, Valentina Assi, Adam Brentnall, et al.
Journal of the National Cancer Institute|May 16, 2022
Benefit of Biennial Fecal Occult Blood Screening on Colorectal Cancer in England: A Population-Based Case-Control StudyAlejandra Castanon, Dharmishta Parmar, Nathalie J Massat, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 20, 2016
Impact of Screening on Breast Cancer Mortality-ResponseNathalie J Massat, Amanda Dibden, Dharmishta Parmar, et al.
Cancer Medicine|July 19, 2022
A case-control study to evaluate the impact of the breast screening programme on breast cancer incidence in EnglandOleg Blyuss, Amanda Dibden, Nathalie J Massat, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 10, 2015
Impact of Screening on Breast Cancer Mortality: The UK Program 20 Years OnNathalie J Massat, Amanda Dibden, Dharmishta Parmar, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 10, 2015
Explaining the Better Prognosis of Screening-Exposed Breast Cancers: Influence of Tumor Characteristics and TreatmentNathalie J Massat, Peter D Sasieni, Daniela Tataru, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Breast Cancer Research : BCR|May 18, 2013
Overdiagnosis in breast cancer screening: the importance of length of observation period and lead timeStephen W Duffy, Dharmishta Parmar
Journal of Medical Screening|September 17, 2019
Concurrent participation in screening for cervical, breast, and bowel cancer in EnglandMatejka Rebolj, Dharmishta Parmar, Roberta Maroni, et al.
BMC Cancer|December 17, 2013
An ongoing case-control study to evaluate the NHS breast screening programmeNathalie J Massat, Peter D Sasieni, Dharmishta Parmar, et al.
BMC Cancer|December 16, 2014
An ongoing case-control study to evaluate the NHS Bowel Cancer Screening ProgrammeNathalie J Massat, Peter D Sasieni, Dharmishta Parmar, et al.
British Journal of Cancer|May 9, 2018
Addition of ultrasound to mammography in the case of dense breast tissue: systematic review and meta-analysisMatejka Rebolj, Valentina Assi, Adam Brentnall, et al.
Journal of the National Cancer Institute|May 16, 2022
Benefit of Biennial Fecal Occult Blood Screening on Colorectal Cancer in England: A Population-Based Case-Control StudyAlejandra Castanon, Dharmishta Parmar, Nathalie J Massat, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 20, 2016
Impact of Screening on Breast Cancer Mortality-ResponseNathalie J Massat, Amanda Dibden, Dharmishta Parmar, et al.
Cancer Medicine|July 19, 2022
A case-control study to evaluate the impact of the breast screening programme on breast cancer incidence in EnglandOleg Blyuss, Amanda Dibden, Nathalie J Massat, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 10, 2015
Impact of Screening on Breast Cancer Mortality: The UK Program 20 Years OnNathalie J Massat, Amanda Dibden, Dharmishta Parmar, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 10, 2015
Explaining the Better Prognosis of Screening-Exposed Breast Cancers: Influence of Tumor Characteristics and TreatmentNathalie J Massat, Peter D Sasieni, Daniela Tataru, et al.
Pageof 2